tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT

Sarepta Therapeutics (SRPT) Technical Analysis

2,792 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Sarepta Therapeutics’s (SRPT) Moving Averages Convergence Divergence (MACD) indicator is 2.13, suggesting Sarepta Therapeutics is a Buy.
Sarepta Therapeutics’s (SRPT) 20-Day exponential moving average is 130.14, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Buy.
Sarepta Therapeutics’s (SRPT) 50-Day exponential moving average is 126.93, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Buy.

Sarepta Therapeutics (SRPT) Pivot Points

May 19, 2024, 01:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
127.01
128.29
130.51
131.79
134.01
135.29
137.51
Fibonacci
128.29
129.62
130.45
131.79
133.12
133.95
135.29
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Sarepta Therapeutics (SRPT) Moving Averages

May 19, 2024, 01:07 PM
Period
Simple
Exponential
MA5
132.20Sell
132.14Sell
MA10
132.88Sell
131.80Sell
MA20
129.70Buy
130.14Buy
MA50
126.40Buy
126.93Buy
MA100
123.00Buy
122.36Buy
MA200
113.56Buy
117.43Buy
Sarepta Therapeutics’s (SRPT) 10-Day exponential moving average is 131.80, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Sell.
Sarepta Therapeutics’s (SRPT) 100-Day exponential moving average is 122.36, while Sarepta Therapeutics’s (SRPT) share price is $131.38, making it a Buy.
Sarepta Therapeutics’s (SRPT) stock price is $131.38 and Sarepta Therapeutics’s (SRPT) 50-day simple moving average is 126.40, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $131.38 and Sarepta Therapeutics’s (SRPT) 100-day simple moving average is 123.00, creating a Buy signal.
Sarepta Therapeutics’s (SRPT) stock price is $131.38 and Sarepta Therapeutics’s (SRPT) 200-day simple moving average is 113.56, creating a Buy signal.

Sarepta Therapeutics (SRPT) Technical Indicators

May 19, 2024, 01:07 PM
Name
Value
Implied Action
RSI (14)
56.17
Neutral
STOCH (9,6)
16.05
Buy
STOCHRSI (14)
29.19
Neutral
MACD (12,26)
2.13
Buy
ADX (14)
42.57
Neutral
Williams %R
-75.93
Buy
CCI (14)
26.09
Neutral
ATR (14)
4.64
-
Ultimate Oscillator
52.52
Neutral
ROC
2.00
Buy
Sarepta Therapeutics’s (SRPT) Relative Strength Index (RSI) is 56.17, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Trend Strength Indicator (ADX) is 42.57, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Commodity Channel Index (CCI) is 26.09, creating a Neutral signal.
Sarepta Therapeutics’s (SRPT) Price Rate of Change (ROC) is 2.00, creating a Buy signal.

FAQ

Is SRPT a Buy, Hold, or Sell?
Based on SRPT’s technical indicators, SRPT is a Buy.
    What is SRPT’s RSI (14)?
    SRPT’s RSI (14) is 56.17, which suggests SRPT is a Neutral.
      What is SRPT’s MACD?
      SRPT’s MACD is 2.13, which suggests SRPT is a Buy.
        What is SRPT’s 5-day moving average?
        SRPT’s 5-day moving average is 132.20, which suggests SRPT is a Sell.
          What is SRPT’s 20-day moving average?
          SRPT 20-day moving average is 129.69, which suggests SRPT is a Buy.
            What is SRPT’s 50-day moving average?
            SRPT’s 50-day moving average is 126.40, which suggests SRPT is a Buy.
              What is SRPT’s 200-day moving average?
              SRPT’s 200-day moving average is 113.56, which suggests SRPT is a Buy.
                What is SRPT’s Williams % R (14)?
                SRPT’s Williams % R (14) is -75.93, which suggests SRPT is a Buy.
                  What is SRPT’s CCI (14)?
                  SRPT’s CCI (14) is 26.09, which suggests SRPT is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis